Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride may improve prostate cancer treatment outcomes.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Four patients with a type of rickets and hair loss had different mutations in their vitamin D receptor gene, causing it to not work properly.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Prolactin affects when mice shed and grow hair.